+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Reviva Pharmaceuticals Inc - logo
Alzheimer's Disease Market (2nd edition) by Type of Treatment (Symptomatic and Disease Modifying), Symptomatic Indications (Dementia, Insomnia and Other Psychological Symptoms) and Geography (North America, Europe and Asia-Pacific), 2021-2030 - Product Thumbnail Image

Alzheimer's Disease Market (2nd edition) by Type of Treatment (Symptomatic and Disease Modifying), Symptomatic Indications (Dementia, Insomnia and Other Psychological Symptoms) and Geography (North America, Europe and Asia-Pacific), 2021-2030

  • Report
  • September 2021
  • 150 Pages
  • Global
From
Obesity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Obesity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 643 Pages
  • Global
From
Schizophrenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Schizophrenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 295 Pages
  • Global
From
Global Schizophrenia Therapeutics Market by Therapeutic Class (Second Generation, Third Generation), Administration (Injectable, Oral), Distribution Channel - Forecast 2023-2030 - Product Thumbnail Image

Global Schizophrenia Therapeutics Market by Therapeutic Class (Second Generation, Third Generation), Administration (Injectable, Oral), Distribution Channel - Forecast 2023-2030

  • Report
  • October 2023
  • 185 Pages
  • Global
From
Alzheimer's Disease: Pipeline Review, Developer Landscape and Competitive Insights - Product Thumbnail Image

Alzheimer's Disease: Pipeline Review, Developer Landscape and Competitive Insights

  • Report
  • March 2019
  • 220 Pages
  • Global
From
Schizophrenia Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 - Product Thumbnail Image

Schizophrenia Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

  • Drug Pipelines
  • September 2022
  • 129 Pages
  • Global
From
5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • May 2022
  • 45 Pages
  • Global
From
5-Hydroxytryptamine Receptor 7 (5 HT7 or 5 HTX or Serotonin Receptor 7 or HTR7) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

5-Hydroxytryptamine Receptor 7 (5 HT7 or 5 HTX or Serotonin Receptor 7 or HTR7) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • May 2022
  • 83 Pages
  • Global
From
Blood-Brain Barrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics - Product Thumbnail Image

Blood-Brain Barrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics

  • Report
  • March 2020
  • 357 Pages
  • Global
From
Obesity - Pipeline Insights, 2022 - Product Thumbnail Image

Obesity - Pipeline Insights, 2022

  • Clinical Trials
  • November 2022
  • 260 Pages
  • Global
From
Depressive Disorders (Major Depression, Bipolar Disorder, Postpartum Depression, Treatment-Resistant Depression, and Others): Pipeline Review, Developer Landscape and Competitive Insights, 2019 - Product Thumbnail Image

Depressive Disorders (Major Depression, Bipolar Disorder, Postpartum Depression, Treatment-Resistant Depression, and Others): Pipeline Review, Developer Landscape and Competitive Insights, 2019

  • Report
  • April 2019
  • 208 Pages
  • Global
From
5-Hydroxytryptamine Receptor 7 (5 HT7 or 5 HTX or Serotonin Receptor 7 or HTR7) - Pipeline Review, H2 2018 - Product Thumbnail Image

5-Hydroxytryptamine Receptor 7 (5 HT7 or 5 HTX or Serotonin Receptor 7 or HTR7) - Pipeline Review, H2 2018

  • Drug Pipelines
  • November 2018
  • 70 Pages
  • Global
From
Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 589 Pages
  • Global
From
Parkinson's Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Parkinson's Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 1079 Pages
  • Global
From
Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets - Product Thumbnail Image

Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

  • Drug Pipelines
  • August 2019
  • 142 Pages
  • Global
From
Global Tourettes Syndrome Drugs Market 2023-2027 - Product Thumbnail Image

Global Tourettes Syndrome Drugs Market 2023-2027

  • Report
  • June 2023
  • 149 Pages
  • Global
From
Obesity - Pipeline Review, H2 2020 - Product Thumbnail Image

Obesity - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 640 Pages
  • Global
From
2019 Future of Attention Deficit Hyperactivity Disorder (ADHD) R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments - Product Thumbnail Image

2019 Future of Attention Deficit Hyperactivity Disorder (ADHD) R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

  • Report
  • February 2019
  • 140 Pages
  • Global
From
Schizophrenia - Pipeline Review, H2 2020 - Product Thumbnail Image

Schizophrenia - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 440 Pages
  • Global
From
Autism (Central Nervous System) - Drugs in Development, 2021 - Product Thumbnail Image

Autism (Central Nervous System) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Loading Indicator